Christoph Schliemann

23PUBLICATIONS
122CO-AUTHORS
Haematological tumoursMedical mycologyEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Aug 18, 2026
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

|Oct 28, 2025
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.

Marius Bill, Jan-Niklas Eckardt, Konstanze Döhner

|Sep 22, 2025
Rapid epigenomic classification of acute leukemia.

Til L Steinicke, Salvatore Benfatto, Maria R Capilla-Guerra

|Jul 21, 2025
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis.

Julian Ronnacker, Philippe J Muller, Jan-Henrik Mikesch

|Jan 15, 2025
Common hereditary variants of the APOE gene and posttransplant outcome in acute myeloid leukemia.

Julian Ronnacker, Michael Grau, Maximilian Klasmeier

|Sep 16, 2024
Single or Double Induction With 7 + 3 Containing Standard or High-Dose Daunorubicin for Newly Diagnosed AML: The Randomized DaunoDouble Trial by the Study Alliance Leukemia.

Christoph Röllig, Björn Steffen, Christoph Schliemann

Pageof 4

Frequent Collaborators

10 joint publications

Stefan W Krause

10 joint publications

Christoph Röllig

9 joint publications

Maher Hanoun

9 joint publications

Claudia D Baldus